Four strategic clusters powered by a shared neural intelligence platform.
The shared foundation powering all research clusters
The Neural Intelligence Engine is our unified technology platform, providing the computational, signal processing, and AI infrastructure that enables breakthrough research across all four research clusters. This shared foundation ensures consistency, accelerates innovation, and maximizes cross-cluster synergy.
Advanced hardware and software for capturing, filtering, and preprocessing brain signals from multiple modalities including EEG, fNIRS, and electrophysiology.
Deep learning systems, foundation models, and AI copilots for neural signal analysis, pattern recognition, and intelligent decision support.
Real-time processing architectures optimized for deployment in clinical and assistive devices with minimal latency and power consumption.
Secure, standardized data management systems supporting multi-site collaboration, longitudinal studies, and ethical data governance.
Evolved from: Prevention
This cluster focuses on AI-driven diagnostic technologies and preventive health applications, leveraging neural signals and digital biomarkers to transform disease detection, monitoring, and population health management.
Machine learning systems for automated detection of seizures, sleep disorders, cognitive decline, and neurological conditions from electroencephalography data.
Personalized computational models of individual neural function for predictive health monitoring and early intervention in cognitive disorders.
Real-time assessment of cognitive load, fatigue, and performance optimization in safety-critical domains including aviation, driving, and manufacturing.
Consumer-grade and clinical-grade wearable systems for continuous neural monitoring, health tracking, and integration with smart health ecosystems.
Evolved from: Rehabilitation & Assistive Technology
This cluster develops BCI-enabled rehabilitation systems and assistive devices, using neural interfaces to facilitate motor recovery, restore communication, and enhance quality of life for individuals with neurological disabilities.
Adaptive therapy systems that use real-time neural feedback to guide motor learning and neuroplasticity-driven recovery following stroke or spinal cord injury.
BCI-controlled interfaces for communication (speech synthesis, text input) and environmental control, empowering locked-in and paralyzed individuals.
Brain-controlled prosthetic limbs with sensory feedback and wearable robotic exoskeletons for enhanced mobility and functional independence.
Remote monitoring and intervention systems enabling decentralized rehabilitation services, extending access to underserved rural and urban populations.
Evolved from: Treatment
This cluster develops and validates closed-loop and open-loop neuromodulation therapies for pain management, psychiatric disorders, and neurological conditions, with emphasis on clinical translation and therapeutic validation.
Responsive neurostimulation systems that detect pain-related neural biomarkers and deliver targeted interventions, minimizing therapy duration and side effects.
Transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and emerging modalities for depression, anxiety, and cognitive dysfunction.
Vagus nerve stimulation, peripheral nerve interfaces, and autonomic nervous system interventions for systemic health outcomes.
Identification and validation of neural signatures predictive of treatment response, enabling precision medicine approaches to neuromodulation therapy.
New Research Frontier
This emerging cluster drives innovation in neural acquisition hardware, electrode technologies, and sensor fusion systems. By advancing the physical interfaces between brain and machines, we enable next-generation BCI performance and clinical deployment.
Application-specific integrated circuits for low-power, high-fidelity neural signal acquisition optimized for specific BCI modalities and use cases.
Soft electronics, graphene-based, and polymer electrodes for comfortable, long-term neural interfacing with reduced foreign body response.
Integrated systems combining EEG, EMG, fNIRS, eye-tracking, and physiological signals for richer neural and behavioral information.
Intelligent algorithms for real-time integration of multi-modal sensor data, enabling context-aware BCI systems deployable on mobile devices.
Systematic pathway from discovery to clinical impact
Fundamental research, proof of concept, feasibility studies
Laboratory prototyping, technology maturation, early validation
Pilot testing, small cohort studies, regulatory pathway planning
Randomized controlled trials, efficacy and safety demonstration
Clinical adoption, guideline development, physician training
Commercialization, manufacturing, market distribution
Throughout all six stages, our translational pipeline is supported by integrated expertise in regulatory affairs, clinical partnerships, IP management, and commercialization strategies. We work closely with hospitals, device manufacturers, startups, and policy makers to ensure discoveries become accessible therapies.